CALGARY, October 24, 2023 – ATMA Journey Centers Inc. (“ATMA”), a Canadian company with a primary focus on advancing psychedelic-assisted therapy,...
The field of psychedelic research lost one of the greats on October 16, 2023. Join us in celebrating the life and contribution of Roland Griffiths.
A study conducted during the COVID-19 pandemic found that individuals who have used psychedelic substances reported lower psychological distress, enhanced...
“The hallmark feature of the mystical experience, that we can now occasion with high probability, is the sense of the interconnectedness of all things...
The Brain & Behavior Research Foundation today announced it is awarding $10.2 million in Young Investigator Grants to 150 promising early career...
The psychedelic medicine community has lost one of its great figures as Dr. Roland Griffiths has passed away. The post Honoring Roland Griffiths: Psychedelic...
Cybin Inc. (NYSE AMERICAN:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
Cybin shareholders approve the acquisition of Small Pharma with 99.4% of the vote. The post Cybin Shareholders Approve Acquisition of Small Pharma appeared...
Research has shown ketamine to have rapid antidepressant effects. The post Ketamine Clinics Hope to ‘Open New Doors’ for Patients with Severe Depression...
A new study in rodents shows that low doses of psilocybin increase resilience to stress and lowers compulsive actions. The post New Study Shows Microdoses...